Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based Resource.

导出 OA

翻译打印收藏纠错

作者： Joel,Morris ^[1] ; Mark W,Kunkel ^[1] ; Stephen L,White ^[1] ; Donn G,Wishka ^[1] ; Omar D,Lopez ^[1] ; Lori,Bowles ^[2] ; Penny,Sellers Brady ^[2] ; Patricia,Ramsey ^[2] ; Julie,Grams ^[2] ; Tiffany,Rohrer ^[2] ; Karen,Martin ^[2] ; Thomas S,Dexheimer ^[2] ; Nathan P,Coussens ^[2] ; David,Evans ^[2] ; Prabhakar,Risbood ^[1] ; Dmitriy,Sonkin ^[1] ; John D,Williams ^[1] ; Eric C,Polley ^[1] ; Jerry M,Collins ^[1] ; James H,Doroshow ^[1] ; Beverly A,Teicher ^[1]

作者单位： Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland. ^[1] Target Validation and Screening Laboratory, Applied and Developmental Research Directorate, Frederick National, Laboratory for Cancer Research, Frederick, Maryland. ^[2]

主题词人类(Humans);细胞系, 肿瘤(Cell Line, Tumor);肿瘤(Neoplasms);抗肿瘤药(Antineoplastic Agents)

DOI 10.1158/1535-7163.MCT-23-0267

PMID 37550087

发布时间 2024-02-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交